The present invention is directed to the treatment and/or prevention of disease as it relates to Rho kinase. In specific embodiments, disease is treated and/or prevented through the administration of an agent that selectively inhibits ROCK1. In specific embodiments, it inhibits ROCK1 and not ROCK2. In other specific embodiments, the disease is cardiac disease.
申请公布号
WO2006053014(A3)
申请公布日期
2006.08.24
申请号
WO2005US40529
申请日期
2005.11.09
申请人
BAYLOR COLLEGE OF MEDICINE;WEI, LEI;SCHWARTZ, ROBERT, J.;CHANG, JIANG;ENTMAN, MARK
发明人
WEI, LEI;SCHWARTZ, ROBERT, J.;CHANG, JIANG;ENTMAN, MARK